Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32749942

Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Oct 20
First author
DiSilvestro P

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jan 20;39(3):256. doi: 10.1200/JCO.20.03081.
    note
    Source null
    related pmid
    33326256
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Jan 20;39(3):255. doi: 10.1200/JCO.20.02467.
    note
    Source null
    related pmid
    33326258
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2021 Apr 20;39(12):1414. doi: 10.1200/JCO.21.00699.
    note
    Source null
    related pmid
    33857390
    relationship
    Erratum in

Authors and identifiers

  1. name
    DiSilvestro P
    type
    Author
  2. name
    Colombo N
    type
    Author
  3. name
    Scambia G
    type
    Author
  4. name
    Kim BG
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Friedlander M
    type
    Author
  7. name
    Lisyanskaya A
    type
    Author
  8. name
    Floquet A
    type
    Author
  9. name
    Leary A
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Gourley C
    type
    Author
  12. name
    Banerjee S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    DiSilvestro P
    type
    Author
  2. name
    Colombo N
    type
    Author
  3. name
    Scambia G
    type
    Author
  4. name
    Kim BG
    type
    Author
  5. name
    Oaknin A
    type
    Author
  6. name
    Friedlander M
    type
    Author
  7. name
    Lisyanskaya A
    type
    Author
  8. name
    Floquet A
    type
    Author
  9. name
    Leary A
    type
    Author
  10. name
    Sonke GS
    type
    Author
  11. name
    Gourley C
    type
    Author
  12. name
    Banerjee S
    type
    Author
bibliography ids
  1. nci-bib-16725c8e84d8ac884449ee9a
book metadata
content sha256
cd47dc4fe51a4125b1278a2680ff6919cb13bc95f1da7110e8239e2fac654fbd
document type
citation
dois
  1. 10.1200/JCO.20.00799
electronic publication date
display
2020 Aug 4
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:32749942
immutable id
pubmed:32749942@cd47dc4fe51a4125b1278a2680ff6919cb13bc95f1da7110e8239e2fac654fbd
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
30
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
3528-3537
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2021 Jan 20;39(3):256. doi: 10.1200/JCO.20.03081.
    note
    Source null
    related pmid
    33326256
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2021 Jan 20;39(3):255. doi: 10.1200/JCO.20.02467.
    note
    Source null
    related pmid
    33326258
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2021 Apr 20;39(12):1414. doi: 10.1200/JCO.21.00699.
    note
    Source null
    related pmid
    33857390
    relationship
    Erratum in
outcomes validated
false
pmid
32749942
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
c28d2d2bfe207ec0f014cf242d02d3746377691cdca312127c593bcbfb970db8
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Oct 20
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32749942/
title
Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial.

Preserved source evidence · Not medical advice